Status:
COMPLETED
DIAGNOSIS of PULMONARY TUBERCULOSIS Through HUMAN BREATH (TBENOSE)
Lead Sponsor:
University of Rome Tor Vergata
Conditions:
Tuberculosis, Pulmonary
HIV Seropositivity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Tuberculosis (TB) is one of the top 10 causes of death in the world. More than 95% of TB deaths are in middle- and middle-income countries. Low incomes and long-term diagnosis promote this persistence...
Detailed Description
It is a 12 -month dynamic, open, descriptive and analytical type case-control study in adults. The present study intends to recruit , all the Pulmonary TB suspects and case notified by TB Loop-mediate...
Eligibility Criteria
Inclusion
- Accept to participate in the study through a signed informed consent approved by the Ethical Committee (CEI of Douala - Cameroon)
- Suspected of having TB on clinical base (4SS + or other clinical suggestions) with HIV+/- status
- Healthy control patient
- Able to produce exhaled air samples
- Able to produce sputum samples for TB LAMP test
Exclusion
- Unable to breath normally for 2 minutes due to respiratory illness
- By discretion of the research team.
Key Trial Info
Start Date :
January 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 5 2021
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04682990
Start Date
January 5 2021
End Date
December 5 2021
Last Update
December 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre des Maladies Respiratoire
Douala, Littoral Region, Cameroon